Assessment of Intratumoral Doxorubicin Penetration after Mild Hyperthermia-Mediated Release from Thermosensitive Liposomes

In solid tumors, rapid local intravascular release of anticancer agents, e.g., doxorubicin (DOX), from thermosensitive liposomes (TSLs) can be an option to overcome poor extravasation of drug nanocarriers. ­e driving force of DOX penetration is the drug concentration gradient between the vascular compartment and the tumor interstitium. In this feasibility study, we used fibered confocal fluorescence microscopy (FCFM) to monitor in real-time DOX penetration in the interstitium of a subcutaneous tumor after its intravascular release from TSLs, ­ermodox®. Cell uptake kinetics of the released DOX was quantified, along with an indepth assessment of released-DOX penetration using an evolution model. A subcutaneous rat R1 rhabdomyosarcoma xenograft was used. ­e rodent was positioned in a setup including a water bath, and FCFM identiŽcation of functional vessels in the tumor tissue was applied based on AngioSense. ­e tumor-bearing leg was immersed in the 43°C water for preheating, and TSLs were injected intravenously. Real-time monitoring of intratumoral (i.t.) DOX penetration could be performed, and it showed the progressing DOX wave front via its native fluorescence, labeling successively all cell nuclei. Cell uptake rates (1/k) of 3 minutes were found (n = 241 cells), and a released-DOX penetration in the range of 2500 µm2 ·s −1 was found in the tumor extravascular space. ­is study also showed that not all vessels, identified as functional based on AngioSense, gave rise to local DOX penetration.